These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28955023)

  • 1. Biopharmaceutical Process Optimization with Simulation and Scheduling Tools.
    Petrides D; Carmichael D; Siletti C; Koulouris A
    Bioengineering (Basel); 2014 Sep; 1(4):154-187. PubMed ID: 28955023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium term planning of biopharmaceutical manufacture using mathematical programming.
    Lakhdar K; Zhou Y; Savery J; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2005; 21(5):1478-89. PubMed ID: 16209554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacity optimization and scheduling of a multiproduct manufacturing facility for biotech products.
    Shaik MA; Dhakre A; Rathore AS; Patil N
    Biotechnol Prog; 2014; 30(5):1221-30. PubMed ID: 25079608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacity planning for batch and perfusion bioprocesses across multiple biopharmaceutical facilities.
    Siganporia CC; Ghosh S; Daszkowski T; Papageorgiou LG; Farid SS
    Biotechnol Prog; 2014; 30(3):594-606. PubMed ID: 24376262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data mining for rapid prediction of facility fit and debottlenecking of biomanufacturing facilities.
    Yang Y; Farid SS; Thornhill NF
    J Biotechnol; 2014 Jun; 179():17-25. PubMed ID: 24637375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial technologies for biotherapeutics production: Key tools for advanced biopharmaceutical process development and control.
    Zalai D; Kopp J; Kozma B; Küchler M; Herwig C; Kager J
    Drug Discov Today Technol; 2020 Dec; 38():9-24. PubMed ID: 34895644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium term planning of biopharmaceutical manufacture with uncertain fermentation titers.
    Lakhdar K; Farid SS; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2006; 22(6):1630-6. PubMed ID: 17137311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Analysis of Batch and Continuous Biopharmaceutical Antibody Production: A Review.
    Yang O; Qadan M; Ierapetritou M
    J Pharm Innov; 2019; 14():1-19. PubMed ID: 30923586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a Digital Bioprocess Replica: Computational Approaches in Biopharmaceutical Development and Manufacturing.
    Smiatek J; Jung A; Bluhmki E
    Trends Biotechnol; 2020 Oct; 38(10):1141-1153. PubMed ID: 32518043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of bioprocess simulation software for industrial applications.
    Shanklin T; Roper K; Yegneswaran PK; Marten MR
    Biotechnol Bioeng; 2001 Feb; 72(4):483-9. PubMed ID: 11180068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-assisted Design of Experiments as a concept for knowledge-based bioprocess development.
    Möller J; Kuchemüller KB; Steinmetz T; Koopmann KS; Pörtner R
    Bioprocess Biosyst Eng; 2019 May; 42(5):867-882. PubMed ID: 30806781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vapor Phase Hydrogen Peroxide Decontamination or Sanitization of an Isolator for Aseptic Filling of Monoclonal Antibody Drug Product-Hydrogen Peroxide Uptake and Impact on Protein Quality.
    Hubbard A; Roedl T; Hui A; Knueppel S; Eppler K; Lehnert S; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(4):348-366. PubMed ID: 29545321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Process Model Applications Linking Bioprocess Development to Quality by Design Milestones.
    Taylor C; Marschall L; Kunzelmann M; Richter M; Rudolph F; Vajda J; Presser B; Zahel T; Studts J; Herwig C
    Bioengineering (Basel); 2021 Oct; 8(11):. PubMed ID: 34821722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint Optimization of Process Flow and Scheduling in Service-Oriented Manufacturing Systems.
    Vargas J; Calvo R
    Materials (Basel); 2018 Aug; 11(9):. PubMed ID: 30158503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioprocess iterative batch-to-batch optimization based on hybrid parametric/nonparametric models.
    Teixeira AP; Clemente JJ; Cunha AE; Carrondo MJ; Oliveira R
    Biotechnol Prog; 2006; 22(1):247-58. PubMed ID: 16454517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of agent-based system for bioprocess description and process improvement.
    Gao Y; Kipling K; Glassey J; Willis M; Montague G; Zhou Y; Titchener-Hooker NJ
    Biotechnol Prog; 2010; 26(3):706-16. PubMed ID: 20014420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-objective AGV scheduling in an FMS using a hybrid of genetic algorithm and particle swarm optimization.
    Mousavi M; Yap HJ; Musa SN; Tahriri F; Md Dawal SZ
    PLoS One; 2017; 12(3):e0169817. PubMed ID: 28263994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
    Reid CQ; Tait A; Baldascini H; Mohindra A; Racher A; Bilsborough S; Smales CM; Hoare M
    Biotechnol Bioeng; 2010 Sep; 107(1):85-95. PubMed ID: 20506289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a fully integrated three-dimensional computed tomography simulator and preliminary clinical evaluation.
    Perez CA; Purdy JA; Harms W; Gerber R; Matthews J; Grigsby PW; Graham ML; Emami B; Lee HK; Michalski JM
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):887-97. PubMed ID: 7960992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.